Baker Chad R »

Crispr Therapeutics shares owned by Baker Chad R

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Baker Chad R from 13F filings

Historical chart of Baker Chad R investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Baker Chad R consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Baker Chad R

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.7M 99k 68.16
2023-12-31 $6.2M 99k 62.60
2023-09-30 $2.4M 52k 45.39

More positions owned by Baker Chad R

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Mastercard Incorporated Common Stock (MA)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Waste Mgmt Inc Del Common Stock (WM)
Amazon Common Stock (AMZN)
Danaher Corporation Common Stock (DHR)
Carrier Global Corporation Common Stock (CARR)
Analog Devices Common Stock (ADI)
Rockwell Automation Common Stock (ROK)
Amphenol Corp Common Stock (APH)
Xylem Common Stock (XYL)
Abbott Labs Common Stock (ABT)
T-mobile Us Common Stock (TMUS)

View all positions for Baker Chad R

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics